| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |